Tolterodine Tartrate Capsule, Extended Release
Product Images NDC 51407-739

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 51407-739). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-739-90ol (Tolterodine Tartrate ER Capsules)

Label of Tolterodine Tartrate extended-release capsules, 2 mg strength, in a 90-capsule bottle. Label includes NDC 51407-739-90 and states pharmacist instructions, storage conditions, and dispensing information. Marketed by GSMS, Incorporated.*

FDA Label Image

51407-740-90ol (Tolterodine Tartrate ER Capsules)

Label for Tolterodine Tartrate extended-release capsules, 4 mg strength, marketed by GSMS, Incorporated. The label includes dosage form, strength, quantity of 90 capsules, NDC 51407-740-90, and storage instructions. It also features a QR code and a barcode, with instructions for pharmacists to dispense patient information.*

FDA Label Image

Tolterodine-01 (D996a5c0 Db7e 4c41 9628 A2a4f9227af4 01)

Chemical structure of Tolterodine Tartrate, showing the detailed molecular arrangement of its components, including aromatic rings and hydroxyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.